Harvard Bioscience Revenue, Profits - HBIO Annual Income Statement

Add to My Stocks
$2.78 $0.02 (0.89%) HBIO stock closing price Aug 22, 2017 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Harvard Bioscience stock price. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from $108.66M to $104.52M and how operating and non operating activities have impacted the HBIO stock. The Harvard Bioscience profit and loss statement for 2016 shows a profit of $-4.3M. Profits have grown from $-19.03M YoY. Apart from this an investor should also check Harvard Bioscience assets and Harvard Bioscience free cash flow. Harvard Bioscience revenue for 2016 is $104.52M. View revenue and profit details for latest and last 10 financial years.

show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec.2016201520142013201220112010200920082007
Harvard Bioscience Net Sales or Revenues
Cost Of Goods Sold (COGS)56.1M59.94M59.31M57.47M58.75M58.6M56.4M44.08M45.89M43.16M
Harvard Bioscience Gross Profit
Research & Development Expense5.39M6.42M4.88M4.15M7.32M5.43M4.7M4.39M4.04M3.7M
Selling General & Admin Expense43.29M41.19M35.26M39.41M39.17M36M34.48M27.38M27.66M25.18M
Income Before Depreciation Depletion Amortization-0.27M1.1M9.19M4.12M5.91M8.82M12.58M9.89M10.44M11.35M
Depreciation Depletion Amortization2.72M2.81M2.57M2.59M2.75M2.74M2.36M1.84M1.96M1.82M
Non Operating Income0.56M-1.04M-1.21M-0.14M-0.35M-0.78M0.02M2.03M-0.44M0.4M
Interest Expense0.64M0.85M0.99M0.95M0.58M0.75M0.67M0.27M0.38M0.36M
Harvard Bioscience Pretax Income
Provision for Income Taxes1.22M15.43M2.06M-0.28M0.69M0.73M-9.45M2.67M2.24M1.97M
Minority Interest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-4.3M-19.03M2.35M0.72M1.53M3.81M19.01M7.13M5.41M7.59M
Extraordinary Items & Discontinued Operations----2.55M0.83M--0.09M-3.73M-8.95M
Harvard Bioscience Net Income (Profit/Loss)
Average Shares used to compute Diluted EPS34.21M33.59M32.17M31.91M29.54M29.82M29.41M29.95M31.35M31.41M
Average Shares used to compute Basic EPS34.21M33.59M32.17M30.38M28.8M28.45M28.97M29.65M30.88M30.65M
Income Before Nonrecurring Items1.68M1.65M7.49M5.3M3.33M5.41M7.73M6.34M6.65M7.41M
Income from Nonrecurring Items-5.99M-20.69M-5.14M-4.58M-1.79M-1.6M11.38M0.8M-1.24M0.19M
Harvard Bioscience Earnings Per Share Basic Net
Harvard Bioscience Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items0.
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common---1.35------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Income statement for another ticker

Before investing one should read a report on Harvard Bioscience stock analysis. It helps to look at the following income statement items:
  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth (See: Harvard Bioscience revenue chart) implies that the company is growing, which has not been the case with Harvard Bioscience. One must stay away from stocks whose revenues are declining.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-4.3M for Harvard Bioscience for 2016. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Harvard Bioscience historical stock prices to check how the price has moved with time. .

Harvard Bioscience Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
Net profit margin
Dividend yield